Cite
HARVARD Citation
Smolen, J. et al. (n.d.). AB0766 Secukinumab provides sustained remission and low disease activity related to disease activity index for psoriatic arthritis (DAPSA): 2 year results from the future 2 study. Annals of the rheumatic diseases. pp. 1323-1324. [Online].